Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV treatment usually requires daily pills, but longer-acting regimens are gaining ground.
Monthly islatravir pills are just one of the long-acting options in the HIV prevention pipeline.
MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.
Early study shows implants delivers protective concentrations of a new antiretroviral for more than 12 months.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.